Nottingham, UK – 11th September 2025 – Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks...
Health Innovation East Midlands and Medilink Midlands confirm renewed collaboration to drive life sciences and innovation
Health Innovation East Midlands and Medilink Midlands are delighted to confirm the signing of a renewed Memorandum of Understanding, marking a strengthened collaboration to drive life sciences and health innovation across the East Midlands. Together, we will develop a joint proposition for consideration by the East Midlands Combined Authority and...
Haughton Design Appoints Dr Ash Ghadar as CEO to Accelerate Growth in Pharma and MedTech
Haughton Design, a leading UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as Chief Executive Officer (CEO) to lead the company’s next phase of growth in the MedTech and Pharmaceutical sectors. Dr Ghadar joined Haughton Design in January 2025 as...
Pioneer and AbbVie team up on a Golden Ticket to accelerate game-changing innovations in human health
Pioneer Group, a specialist in life science infrastructure and venture building, has once again teamed up with global biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and...
TBAT Innovation Joins the Dains Group to Expand R&D and Innovation Services Nationwide
We’re proud to announce that TBAT Innovation has officially joined the Dains Group, one of the UK’s fastest-growing accountancy and advisory firms. This exciting development marks a significant milestone in TBAT’s journey and opens a new chapter of growth and enhanced service delivery. Founded in 2002, TBAT Innovation has spent over...
New Accelerator Programme to drive breakthroughs in managing chronic conditions
Pioneer Group, a specialist in life science infrastructure and venture building, has launched a new Accelerator Programme for early-stage life science companies targeting unmet needs in the management of chronic conditions. Funded by the Innovate UK Biomedical Catalyst, in collaboration with the Medical Research Council, the Accelerator has been designed...
New research confirms growing investor interest in later-stage life science companies
Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies. The report also highlights a persistent regional imbalance, with ‘Golden Triangle’ university spinouts attracting significantly more funding than those elsewhere. Whilst the number of deals...
Pair of Senior Associate promotions at Forresters
Two colleagues at Birmingham-based intellectual property firm Forresters, Dr William Powell and Ian Duncan, were recently promoted, becoming Senior Associates at the firm. Ian is a UK Chartered and European Patent Attorney based in our Birmingham office. Since joining Forresters in 2018, Ian has utilised his significant expertise in aerospace...
Coadax appoints corporate finance director to strengthen M&A expertise
Coadax appoints corporate finance director to strengthen M&A expertise Midlands-based M&A advisory firm Coadax has appointed Kiran Tailor as corporate finance director – marking a significant step in its national growth strategy. Kiran joins with more than 15 years’ experience in M&A and transaction advisory, having held senior positions across...
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery
Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines. The project, led by...









